Biological monitoring and the influence of genetic polymorphism of As3MT and GSTs on distribution of urinary arsenic species in occupational exposure workers by Beata Janasik et al.
1 3
Int Arch Occup Environ Health (2015) 88:807–818
DOI 10.1007/s00420-014-1009-7
ORIGINAL ARTICLE
Biological monitoring and the influence of genetic polymorphism 
of As3MT and GSTs on distribution of urinary arsenic species 
in occupational exposure workers
Beata Janasik · Edyta Reszka · 
Magdalena Stanislawska · Edyta Wieczorek · 
Wojciech Fendler · Wojciech Wasowicz 
Received: 27 June 2014 / Accepted: 1 December 2014 / Published online: 10 December 2014 
© The Author(s) 2014. This article is published with open access at Springerlink.com
can be a reliable biological indicator of occupational expo-
sure to arsenic. This study demonstrates that As3MT and/
or GSTs genotype may influence As metabolism. Neverthe-
less, further studies investigating genetic polymorphism in 
occupational conditions are required.
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Introduction
Arsenic (As) is a significant global environmental toxicant 
and As contamination of soil, and drinking water is a prob-
lem threatening human health all over the world. Humans 
are exposed to As through the intake of air, food and water 
and occupational exposure occurs in several industries 
including gold mining and smelting operations. It is well 
established that chronic exposure to As is associated with 
skin, lung and bladder cancers (IARC 1987; Helene et al. 
2007; Järup et al. 1989; Lauwerys and Hoet 2001) as well 
as vascular diseases and hepatotoxicity (NRC 2001). The 
biotransformation pathway of As consists of several change 
in the oxidative state, oxidative methylation, producing at 
least four metabolites (Fig. 1). Inorganic As (iAs) is metab-
olized by reduction in pentavalent iAs to the trivalent form 
(AsIII), followed by oxidative methylation to monomethyl-
ated As (MMA), further reduction from pentavalent MMA 
to trivalent one and final methylation to dimethylated As 
(DMA) (Vahter 1999, 2002). Recently, a reductive methyl-
ation pathway has also been described (Tseng 2009). Meth-
ylated As is less toxic than the inorganic form, and meth-
ylation has been considered to be a detoxification reaction. 
However, recent studies have shown that methylated AsIII 
is more cytotoxic and genotoxic than arsenate and arsenite 
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(Styblo et al. 2000). Following arsenic exposure, 40–60 % 
of arsenic intake is eliminated through urine. It should 
also be mentioned that the majority of the environmentally 
exposed population groups studied so far have on average 
10–30 % of inorganic As, 10–20 % of MMA and 60–70 % 
of DMA in urine, but considerable inter-individual varia-
tions have been observed, which may be a result of genetic 
polymorphism in the methylation capacity of arsenic 
(Vahter 1999).
Due to differences in toxicity of various arsenic forms, 
a speciation analysis is needed to distinguish between its 
toxic and non-toxic forms. Therefore, speciation analysis is 
required to clarify the health risk of arsenic intake.
Urinary levels of arsenic are generally regarded as a 
good measure and biomarker of exposure, although meas-
urements of total arsenic in urine do not contain informa-
tion concerning arsenic species, thereby complicating the 
assignment of toxicity and potential health risk of various 
species of As. Quantitative determination of the amount of 
a specific element is particularly important and that is why 
speciation methods are considered essential for drawing 
accurate conclusions in arsenic exposure and risk assess-
ment. For many years, biological monitoring of occupa-
tional exposure to arsenic has been based on the deter-
mination of the sum of iAs and methylated metabolites 
DMA and MMA in urine. Over 30 arsenic species have 
been identified, including inorganic arsenic species (triva-
lent and pentavalent), methylated species, arsenosugars, 
arsenolipids and thio-arsenic species (Morton and Mason 
2006). Although seafood has been traditionally regarded as 
a source of organoarsenic compounds, there is evidence of 
additional sources such as wild mushrooms, rice and plant 
species (Orloff et al. 2009). This fact may modify urinary 
excretion of the metabolites and thereby affect the speci-
ficity of this method. Presence of As species in the diet 
may lead to overestimation of occupational exposure if 
the workers have eaten fish and/or seafood within the 48 h 
prior to the testing (Airbouine and Wilson 1992).
Arsenic metabolism is regulated by several transferase 
genes.
Two main groups of genes have been associated with 
arsenic metabolism: As3MT (methyltransferases) and GSTs 
(glutathione S-transferases). Both oxidative and reduc-
tive metabolic pathways of arsenic (III) methyltransferase 
(As3MT), previously called Cyt19, play an important role 
in As methylation. The human As3MT gene is approxi-
mately 32-kb long and it is composed of 11 exons (Wood 
et al. 2006). Genetic factors are among the critical fac-
tors for As metabolism (Vahter 2000). Non-synonymous 
SNPs in the As3MT coding regions: Arg173Trp, C>T 
(rs35232887) in exon 6, Met287Thr, T>C (rs11191439) in 
exon 9 and Thr306Ile, C>T (rs34566438) in exon 10 were 
extensively investigated. The Met287Thr polymorphism 
has been found to be related to an increased percentage of 
MMA in urine of the Central European population (Lind-
berg et al. 2007) and miners in Chile (Hernandez et al. 
2008). Polymorphism in the promoter regions, including 
5′UTR As3MT (rs7085104), may affect the expression of 
the As3MT gene, which in turn is likely to affect the metab-
olite pattern. GST is an enzyme that detoxifies xenobiot-
ics via a conjuction reaction with glutathione (GSH), and it 
has been suggested that polymorphic variants may result in 
having different capacities to metabolize arsenic. However, 
data regarding the methylation capacity of iAs or MMA, 
associated with these SNPs, are inconsistent (Engström 
et al. 2009).
The purpose of the present study was to evaluate the 
impact of 4 polymorphisms (rs11191439, rs7085104, 
rs3740393, rs3740400) in As3MT and two polymorphisms 
in GST (GSTP1 rs 1695, GSTO2 rs156697) on As metab-
olism in a Polish sub-population occupationally, but not 
environmentally, exposed to As. The second aim of the 
study was to compare validity of various biomarkers of 
exposure to arsenic in occupational setting and to find out 
whether determination of iAs or the sum of iAs and MMA 
in urine would be useful for the purpose of assessment of 
exposure to inorganic arsenic.
Materials and methods
Subjects and samples
This study was performed on copper mill workers (males 
n = 149) from the southwestern part of Poland with the 
mean age of 47.6 ± 8.7 (range 26–61). They were equipped 
with protective clothing as well as with half face mask 
respirators. Urine and blood samples were collected after 
Fig. 1  Scheme of oxidative methylation of arsenite (Reichard and Puga 2010). As3MT arsenic (+3 oxidation state) methyltransferase, GSTO 
glutathione S-transferase Ω
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their shifts. Before samples collection, the workers were 
asked to remove their work clothes and wash their hands. 
In order to ascertain data on the excretion of arsenic spe-
cies in the general population, 52 men, with the mean age 
of 41.8 (range 28–58), were assessed as a control group. 
They were not occupationally exposed to As and lived in 
areas not polluted with arsenic from industrial plants. Each 
worker and control was asked to complete a questionnaire 
including detailed information, inter alia, on the frequency 
of intake of fish or other seafood. The study was approved 
by the Ethics Committee of the Nofer Institute of Occupa-
tional Medicine in Lodz. The characteristics of the exam-
ined population are shown in Table 1.
Analyses of As in the air (As-A)
Air samples were collected via the individual dosimetry 
method in the breathing zone of each worker continuously 
throughout a 6–7-h period of time in accordance with the 
sample collecting procedure contained in PN-Z-04008-
7:2002. During the collection process, an individual dust 
measuring device was applied (Personal Air Samples, Vor-
tex Standard and Vortex Standard 2 by Casella, and also 
EHA AIR-300 by Ekohigiena). It was used to collect the 
total dust at the flow of 2 l/min. The samples were collected 
on membrane filters made of cellulose nitrate (Sartorius 
11304, diameter of pores—0.8 µm, filter diameter—37 mm) 
(Goettingen, Germany) and of fiberglass (Whatman GF/A, 
diameter 37 mm) (Buckinghamshire, UK). The total dust 
was collected by placing 1–3 filters simultaneously in the 
breathing zone of each study participant. In order to deter-
mine arsenic and its compounds in the air of the workplace, 
the method of inductively coupled plasma mass spectrome-
try (ICP-MS) was applied (version offered by NIOSH Man-
ual of Analytical Methods, Fourth Edition Method 7301, 
Issue 1, 2003, Elements by ICP (Aqua Regia Ashing) and 
Method 7901, Issue 2, 1994, Arsenic Trioxide, as As).
ELAN DRC-e ICP-MS with Dynamic Reaction Cell 
(Perkin Elmer, SCIEX, USA) was used for the purpose of 
arsenic determination in dust.
Analyses of As in urine (As-U)
Urine samples were collected from the workers as well as 
from the controls. Workers provided spot urine samples 
immediately after the shift-end on the second day after 
exposure. The samples were collected after the workers had 
removed their work clothes and washed their hands. The 
control subjects provided spot urine samples the morning 
they came to the laboratory. In all the urine samples, creati-
nine content was determined.
To limit the interconversion of As species, urine sam-
ples were frozen after collection and stored at <−20 °C 
until analysis. Prior to the dilution, the samples were 
centrifuged at 4,000 rpm for 10 min and next, the super-
natant was diluted tenfold with 1.0 % HNO3 for the total 
arsenic and the mobile phase for the speciation analysis. 
ELAN DRC-e ICP-MS with a Dynamic Reaction Cell 
(Perkin Elmer, SCIEX, USA) was used for arsenic deter-
mination. A cyclonic spray chamber, a Meinhard nebu-
lizer and a peristaltic four-channel pump were used. The 
instrument Series 200 HPLC (Perkin Elmer, SCIEX, 
USA) was applied to separate arsenic chemical forms. An 
Anion Exchange, Hamilton PRP-X100 column (4.1 mm 
i.d. × 250 mm × 10 µm) was used under the following 
conditions: 5 mM (NH4NO3) ammonium nitrate/5 mM 
(NH4H2PO4) (dibasic), flow rate 1.5 ml/min, injection vol-
ume 100 µl.
Certified reference material SRM 2669 (human urine) 
from the National Institute of Standard and Technology 
(NIST) with a certified range of (values determined by 
laboratory) Astot.44.4–57.0 µg/l (50.2 ± 5.4); AsIII 4.72–
5.34 µg/l (4.95 ± 0.71); AsV 5.21–7.11 µg/l (5.76 ± 0.31); 
MMA-6.62–7.74 µg/l (7.05 ± 0.55); DMA-24.6–26.0 µg/l 
(25.5 ± 1.5); AsB-1.35–1.51 µg/l (1.40 ± 0.08) were 
examined at the beginning and at the end of the analysis. 
The laboratory participates in the external quality program 
for the total arsenic determination organized by the Insti-
tute of Occupational Social and Environmental Medicine 
of the University of Erlangen, Nuremberg (G-EQUAS). To 
evaluate the efficiency of the first and the second step of 
Table 1  Characteristics of the studied groups
Workers exposed occupationally (n = 149) Control group (n = 52)
Mean ± SD and range/or frequency Mean ± SD and range/or frequency
Age (years) 47.6 ± 8.7 (26–61) 42.0 ± 10.2 (28–58)
Smoking history
Never 72 (48.3 %) 20 (38.5 %)
Former 20 (13.4 %) 17 (32.6 %)
Current 57 (38.3 %) 15 (28.8 %)
BMI (kg/m2) 28.4 ± 3.4 (20.0–42.0) 26.7 ± 3.4 (18.5–38.9)
Period of As exposure (years) 23.2 ± 10.9 (1–41) –
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methylation, the ratios of inorganic arsenic and metabolites 
were calculated.
Analytical performance
HPLC–ICP-MS method was used for the measurement of 5 
arsenic species (AsIII, AsV, MMA, DMA and AsB) (Rabieh 
et al. 2008; Suzuki et al. 2009). The ICP-MS instrument 
was used in dynamic reaction cell mode (DRC). The lim-
its of detection (LODs) were, respectively: Astot.:0.026; 
AsIII:0.045; AsV:0.11; MMA:0.12; DMA:0.07 and 
AsB:0.027 µg/l. The LOD was calculated as three times 
the standard deviation from the lowest concentration from 
the calibrate curve. All the species were separated, and all 
peaks have eluted in 10 min. Arsenic species were cali-
brated in range 1–100 µg/l.
Creatinine determination
Creatinine was determined using colorimetric Jaffe method 
[Über den Niederschlag, welchen Pikrinsäre in normalem 
Harn erzeugt und über eine neue Reaction des Kreatinins 
by Max Jaffe (1886)]. Analysis was carried out at 520 nm 
on Lambda EZ210 spectrometer PerkinElmer (USA).
Genotyping of polymorphisms in As3MT/GSTs
Genomic DNA was isolated from the whole blood samples 
using QIAamp DNA Blood Mini Kit (Qiagen). Genotyp-
ing of As3MT Met287Thr; T>C in exon 9 (rs7085104) 
(Assay ID: C_3284563_10); A>G 5′ terminal polymor-
phism (rs11191439) (Assay ID: C_31979150_10); As3MT 
C>G (rs 3740393) in intron 6(Assay ID: C_25804287_10); 
As3MT T>G (rs 3740400) in intron 1(Assay ID: 
C_27510174_10); GSTP1 Ile105Val (rs 1695) (Assay ID: 
C_3237198_20) and GSTO2 T>C (rs 156697) Assay ID: 
C_3223136_1) was conducted by real-time PCR CFX96 
System (BioRad, Hercules, CA, USA) assays using pre-
design 5′ nuclease allelic discrimination (TaqMan®) assays 
with Genotyping Master Mix (Applied Biosystems, Foster 
City, CA, USA).
Statistical analyses
We tested the deviation from the Hardy–Weinberg equi-
librium using the Chi-square test. Shapiro–Wilk test was 
used to determine the normality of distribution. Variables 
which deviated from normality underwent logarithmic 
transformation and were presented in the text as geomet-
ric means with geometric standard deviations. For pairwise 
comparisons, the Student’s t test was applied and for com-
parisons of more than two groups, the analysis of variance 
(ANOVA) was performed instead with Tukey’s test for post 
hoc comparisons. The effects of the studied polymorphisms 
were tested for both: polymorphic allele carriage effect and 
polymorphic allele homozygosity. Correlations were evalu-
ated using the Pearson’s correlation tests. Multivariate anal-
yses were performed using general linear regression mod-
els. The level of p < 0.05 was considered as statistically 
significant. All statistical analyses were performed using 
the Statistica (Statsoft, Tulsa, OK, USA) software package.
Results
Concentration of As in the air
The airborne arsenic concentrations (As-A), measured 
using individual sampling, varied from 0.2 to 275.6 µg/m3. 
The geometric mean of arsenic concentration in the air was 
higher than MAC (maximum admissible concentration) 
valid in Poland, equal 10 µg/m3. Concentrations above the 
MAC value were found in 82 cases among the 149 inves-
tigated subjects. None of the controls had elevated As-A 
levels. We found weak but statistically significant linear 
correlations between arsenic concentration in the air and 
urinary AsIII (r = 0.334; p < 0.05); AsIII + AsV (0.300; 
p < 0.05) and AsIII + AsV + MMA (r = 0.286; p < 0.05) 
levels in the copper mill workers. No statistically signifi-
cant correlation was found between air As concentration 
and AsIII + AsV + MMA + DMA and Astot in urine of the 
copper mill workers (Table 2).
Concentration of the total As (Astot..) and As species 
in urine
The levels of the total arsenic (Astot.), inorganic arsenic 
(AsIII, AsV) and metabolites (MMA and DMA) were deter-
mined in the urine samples of 149 copper mill workers and 
52 control subjects. The influence of age, BMI, time of 
exposure and smoking habits on As and metabolites concen-
tration was investigated. The results of speciation analysis 
of arsenic in urine of the copper mill workers and in control 
group are presented in Table 3. In 81 cases, the concentra-
tions of Astot. in urine were under the values of biological 
exposure index currently valid in Poland (35 µg/l). Total 
urinary arsenic concentrations, as well as urinary arsenic 
species levels in urine of the copper mill workers were sig-
nificantly higher (p < 0.05) than the concentrations and lev-
els observed in the control group (Table 3). In the control 
group, AsB was excreted most often, then DMA and MMA. 
Inorganic arsenic in the majority of cases was below the 
limit of quantification. We proved that either Astot. or DMA 
and AsB levels in urine of the workers who confirmed fish 
consumption about 3 days before examination were sta-
tistically higher (p < 0.05) than those in the workers who 
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did not confirm fish consumption (respectively, 56.8 ± 3.1 
vs. 33.0 ± 2.2; 25.7 ± 3.6 vs. 15.6 ± 2.5; 19.3 ± 4.3 vs. 
3.6 ± 3.1). Similar trend of urinary As excretion depend-
ing on fish consumption was proved within the control 
group, but concentrations of As species were significantly 
lower as compared to the workers group (p < 0.001) (for As 
tot. 22.7 ± 4.2 vs. 4.0 ± 1.9 µg/l; for DMA 10.9 ± 2.8 vs. 
2.7 ± 2.0 µg/l; for AsB 8.6 ± 7.9 vs. 0.6 ± 2.1 µg/l). Sta-
tistically significant differences between Astot. and iAs con-
centrations in the copper mill workers in relation to smoke 
addiction were observed. Smokers had significantly higher 
(p < 0.05) Astot. concentration as compared to the controls 
(46.4 ± 2.6 vs. 33.7 ± 2.2 µg/l) and significantly higher 
(p < 0.001) iAs concentration (7.6 ± 2.6 vs. 5.7 ± 3.3 µg/l).
Haplotype analysis
Haplotype analysis of the four genotyped loci in As3MT 
showed that rs11191439 and rs3740393 were in high link-
age disequilibrium similarl to rs3740400 and rs7085104. 
Therefore, only rs3740393 and rs3740400 were chosen 
for the adjusted multivariate analysis. The effects were the 
strongest for the rs3740400 genotypes and were signifi-
cantly associated with higher %iAs. (Table 4; Fig. 2).
Genetic polymorphism in As3MT/GSTs and As species 
in urine
All polymorphisms were consistent with the frequencies 
expected from the Hardy–Weinberg Equilibrium (Rodri-
guez et al. 2009) (Table 5). In the analyzed occupational 
exposure group, two individuals (1.3 %) with two vari-
ant As3MT CC (rs11191439) alleles and four individuals 
(2.7 %) with two variant As3MT GG (rs3740393) alleles 
were recorded. The results showed significant associations 
between As3MT G>C (rs3740400) and the As concentra-
tion and metabolite pattern in the urine of the occupation-
ally exposed workers. The workers with variant As3MT GG 
allele homozygotes were characterized by a higher percent-
age of iAs than CC+CG common homozygotes/heterozy-
gotes (Table 4). On the other hand, As3MT Met287Thr 
(T>C) (rs11191439); As3MT A>G (rs7085104); As3MT 
C>G (rs3740393) polymorphisms had no significant rela-
tion to any of the indicators of the As exposure and meta-
bolic capacity.
Significant associations were noted (Table 4) between 
GSTO2 (rs156697) and the As concentration and the 
metabolite pattern in urine, but not for GSTP1 (rs1695). No 
statistically significant differences were stated with regard 
to the distribution of individual alleles between the workers 
and the control group (Table 6).
Discussion
Carrying out biological monitoring for assessment of expo-
sure to inorganic arsenic both in occupational as well as 
environmental exposure is based mostly on the assessment 
of concentrations of arsenic and its metabolites in urine as 
biomarkers of exposure. In the past, the tool for biological 
monitoring of exposure to iAs was performance of assess-
ment based on determinations of the total arsenic. It was 
due to the lack of suitable analytical techniques allowing for 
separation of individual chemical forms of As. That kind of 
biomonitoring made it possible to assess exposure from all 
sources, simultaneously favouring overestimation of expo-
sure due to the presence of organic forms (AsB, AsCh) 
coming mainly from the food, and it increased the concen-
tration sometimes to even more than 200 µg/l. Currently, 
biological monitoring of occupational exposure assessment 
is based on determination of the sum of inorganic arsenic 
concentrations and main methylated metabolites, MMA 
acid and DMA in urine. In the carried out studies aiming 
at verification of the usefulness of determination of the sum 
of iAs +MMA + DMA as a biomarker of exposure, a lin-
ear, statistically significant correlation between inorganic 
arsenic concentrations in the air and concentrations of inor-
ganic arsenic and the sum of iAs and MMA in urine in the 
samples collected at the end of a work shift was obtained. 
Similar correlations have been presented by others authors 
involved in the assessment of occupational exposure to iAs 
(Hakala and Pyy 1995; Offergelt et al. 1992). A statistically 
significant correlation between iAs concentrations in the air 
and the currently applied biomarker (iAs + MMA + DMA) 
Table 2  Relationship between inorganic arsenic concentration in the air and different forms of the biomarkers in urine
* Statistically significant at p < 0.05
As2O3 in air (µg/m
3) GM ± GSD Arsenic metabolites N Regression equation Correlation coefficient
27.6 ± 4.9 AsIII 149 y = 17.20 + 1.85x r = 0.334*
AsIII + AsV 149 y = 17.99 + 1.13x r = 0.300*
AsIII + AsV + MMA 149 y = 17.24 + 0.80x r = 0.286*
AsIII + AsV + MMA + DMA 149 y = 19.82 + 0.24x r = 0.188
As total 149 y = 26.30 + 0.04x r = −0.09
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was not obtained. It is probably a result of the increased 
concentrations of DMA acid, especially in the individuals 
who confirmed the intake of fish meals before the study. 
Content of DMA acid in the food of sea origin was con-
firmed in scientific reports; however, an increased content 
of this compound may be also a result of catabolic trans-
formations of other organic compounds of arsenic such as 
arsenosugars or arsenolipids coming from other types of 
food but having influence on DMA concentrations (Air-
bouine and Wilson 1992; Soleo et al. 2008; Navas-Acien 
et al. 2011). In the case of the individuals who declared an 
increased intake of fish and seafood, statistically significant 
differences were stated not only with regard to concentra-
tions of Astot and AsB, but also in DMA concentrations in 
comparison with the individuals who did not eat fish and 
seafood (25.7 do 15.6 µg/l, p < 0.05). Similar results have 
been achieved by Navas-Acien et al. (2011). Since fish and 
seafood, as Navas-Ancien et al. claim, are the main reason 
for a high concentration of As in urine, the authors propose 
to use Astot minus AsB as a marker of exposure to inorganic 
arsenic. Other authors, among others Hata et al. (2007), pro-
posed to consider the sum of concentrations of iAs + MMA 
with exclusion of DMA as a marker of exposure to arsenic. 
Such a form of biomonitoring was also proposed by other 
authors (Hakala and Pyy 1995; Offergelt et al. 1992; Apos-
toli et al. 1999), suggesting the values of admissible con-
centration of inorganic arsenic in urine (6.7, 6.2 and 5 µg/l) 
and referring them to a maximum admissible concentration 
of iAs in the air of the workplace as proposed by ACGIH—
10 µg/m3 (current threshold limit value set by the Ameri-
can Conference of Governmental and Industrial Hygien-
ists) (ACGIH 2014). Based on the carried out studies and 
obtained correlations (Table 2) between concentrations of 
iAs in the air and individual biomarkers in urine, the val-
ues of concentrations of iAs and the sum of iAs + MMA 
were calculated and proposed as a reference to the cur-
rently applying admissible value in the air of the workplace 
(TLW-TLV–10 µg/m3). For iAs concentrations in urine, 
the obtained value is 8.2 µg/l and it is similar to the values 
proposed by others authors (Hakala and Pyy 1995; Offer-
gelt et al. 1992; Apostoli et al. 1999), while in the case of 
the sum of iAs + MMA, this value equals 12.7 µg/l. As it 
was shown in the control group, DMA and AsB constituted 
the majority of speciation forms of arsenic, then there was 
MMA. Inorganic forms constituted only a minor percent 
(Table 3). Similar distribution of concentrations of chemical 
forms of arsenic was obtained for the not exposed popula-
tions (Navas-Acien et al. 2011; Morton and Mason 2006; 
Caldwell et al. 2009). Therefore, recognition of concentra-
tions of iAs or the sum of concentrations of iAs + MMA as 
biomarkers of assessment of occupational exposure to arse-
nic seems to be justified. On the other hand, a clear influ-





































































































































































































































































































































































































































































































































813Int Arch Occup Environ Health (2015) 88:807–818 
1 3
associated with genetic polymorphisms of metabolising 
enzymes, requires attention to this aspect of the next to the 
biomarkers of exposure.
Methylation of inorganic As to MMA and DMA is an 
important reaction in As biotransformation. Individual 
variations in inorganic As metabolism may influence the 
toxic effects. The most important role in arsenic metabo-
lism in humans is played by As3MT and GSTs, and its 
genetic polymorphism may be associated with the sus-
ceptibility to inorganic arsenic toxicity. Results of As3MT 
genotype-dependent differences in As metabolism for most 
SNPs in As3MT were obtained in several studies involv-
ing individuals exposed environmentally to high As levels 
in water, especially from Asia and South America (Agusa 
et al. 2009, 2011; Engström et al. 2007, 2011; Fujihara 
et al. 2007, 2009; Hernandez et al. 2008; Meza et al. 2005). 
In the case of GSTs, the number of reports is smaller and 
they primarily refer to the populations of Asia and South 
America (Agusa et al. 2010; Caceres et al. 2010; Marcos 
et al. 2006; De Chaudhuri et al. 2008).
In the present study, we investigated the influence of 
four genetic polymorphisms of As3MT and two polymor-
phisms of GSTs that may be involved in As metabolism 
in occupationally exposed workers from the southwestern 
part of Poland. It was observed that As3MT polymorphism 
(rs 11191439, SNP ID 14458) in exon 9 and As3MT (rs 
3740393, SNP ID 12390) in intron 6 may have an impact 
on the As methylation capacity in individuals chronically 
exposed to arsenic in drinking water (Agusa et al. 2009; 
Engström et al. 2007; Hernandez et al. 2008). The role of 
As3MT 5′UTR polymorphism (rs7085104, SNP ID 4602) 
has been studied in few works; however, the same loca-
tion in the promoter region suggests a significant effect on 
the As methylation capacity (Agusa et al. 2011). As3MT 
polymorphism (rs 3740400, SNP ID 5194) in intron 1 
was tested only by Engström et al. (2011) in the popula-
tions of Argentina and Bangladesh. The genotype frequen-
cies for As3MT Met287Thr, T>C and As3MT 5′UTR are 
consistent with the results of other authors as regards the 
Table 4  Significance of the As3MT (rs3740400) and GSTO2 (rs156697) genotypes in the excretion profiles in the exposed group
Equations for the regression models are given below the table—all the models were built for log-transformed variables
# Log(iAs) = 2.485 + 0.014*Age−0.014*work duration + 0.034 (if rs3740400 G carrier)
& Log(%MMA) = 2.614−0.004*Age−0.001*work duration −0.044 (if rs156697 C carrier)
* Log(MMA/iAs) = 0.068−0.018*Age + 0.011*work duration −0.145 (if rs156697 C carrier)
$ Log(DMA/MMA) = 1.478−0.003*Age + 0.004*work duration + 0.161 (if rs156697 C carrier)
As3MT rs3740400 p p for polymorphic 
allele carriage
p adjusted for age, 
work-years
p for polymorphic 
homozygote
p adjusted for age, 
work-years
%iAs TT N = 51 16.2 ± 2.02 0.085 0.567 0.586 0.028 0.097#
TG N = 67 15.7 ± 2.1
GG N = 31 21.8 ± 2.0
GSTO2 rs 156697
%MMA TT N = 67 13.5 ± 1.8 0.028 0.007 0.013 0.572 0.656&
TC N = 70 10.1 ± 2.0
CC N = 12 10.4 ± 2.1
MMA/iAs TT N = 67 0.7 ± 2.4 0.145 0.049 0.046 0.577 0.567*
TC N = 70 0.5 ± 2.2
CC N = 12 0.5 ± 3.2
DMA/MMA TT N = 67 3.5 ± 2.2 0.055 0.016 0.027 0.477 0.547$
TC N = 70 4.9 ± 2.2
CC N = 12 5.0 ± 2.3
Fig. 2  LD values for As3MT SNPs
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Table 5  Geometric mean concentrations of different forms of As in urine and their ratios according to SNPs of the As3MT and GST distribution 
in the occupationally exposed workers
p for HWE p < 0.05
SNP ID n iAs (%) (range) DMA (%) (range) MMA (%) (range) DMA/MMA (range) MMA/iAs (range)
As3MT C>G rs 3740393
CC 100 16.2 ± 2.2 (2.9–53.4) 47.9 ± 1.6 (22.0–88.2) 11.1 ± 1.9 (2.2–35.3) 4.3 ± 2.4 (1.1–39.3) 0.6 ± 2.4 (0.07–8.3)
CG 45 18.9 ± 1.9 (3.6–70.2) 49.3 ± 1.4 (8.7–85.8) 12.8 ± 1.8 (3.5–32.6) 3.8 ± 2.2 (1.4–24.8) 0.6 ± 2.3 (0.05–3.3)
GG 4 17.0 ± 2.2 (5.7–31.5) 50.9 ± 1.3 (37.1–67.1) 9.4 ± 2.6 (3.9–37.1) 5.4 ± 3.3 (1.0–17.0) 0.4 ± 4.4 (0.2–3.71)
As3MT T>C rs 3740400
TT 51 16.2 ± 2.02 (1.9–39.7) 49.8 ± 1.4 (22.0–74.4) 10.7 ± 1.9 (2.2–32.6) 4.6 ± 2.4 (0.5–32.8) 0.6 ± 2.5 (0.07–8.3)
TG 67 15.7 ± 2.1 (2.9–55.9) 48.7 ± 1.6 (4.6–88.2) 11.3 ± 2.0 (2.3–37.1) 4.3 ± 2.6 (1.0–17.6) 0.6 ± 2.4 (0.05–5.3)
GG 31 21.8 ± 2.0 (6.1–70.2) 45.4 ± 1.5 (8.7–70.9) 13.6 ± 1.7 (3.9–29.6) 3.3 ± 2.0(1.0–17.0) 0.6 ± 2.4 (0.2–3.9)
GSTP1 rs 1695
Ile/Val 52 19.0 ± 1.8 (5.4–40.5) 48.5 ± 1.4 (11.4–85.8) 11.4 ± 1.8 (2.1–30.9) 4.2 ± 2.2 (0.5–32.8) 0.5 ± 2.0 (0.15–1.7)
Ile/Ile 81 16.4 ± 2.2 (1.9–70.2) 48.4 ± 1.6 (4.6–89.3) 11.5 ± 2.0 (2.2–37.1) 4.2 ± 2.5 (1.0–39.3) 0.6 ± 2.7 (0.05–8.3)
Val/Val 15 14.3 ± 2.1 (3.3–50.8) 47.7 ± 1.6 (14.7–72.8) 12.2 ± 1.7 (4.5–35.3) 3.9 ± 2.4 (0.4–10.5) 0.7 ± 2.2 (0.18–2.9)
GSTO2 rs 156697
TT 67 17.1 ± 2.2 (1.9–70.2) 47.2 ± 1.5 (8.7–88.2) 13.5 ± 1.8 (2.1–35.3) 3.5 ± 2.2 (1.1–14.5) 0.7 ± 2.4 (0.4–8.3)
TC 70 16.6 ± 2.0 (1.9–53.4) 49.0 ± 1.6 (4.6–89.3) 10.1 ± 2.0 (2.2–37.1) 4.9 ± 2.5 (0.5–39.3) 0.5 ± 2.2 (0.07–3.7)
CC 12 19.3 ± 2.1 (6.9–55.9) 51.7 ± 1.3 (35.5–73.9) 10.4 ± 2.1 (2.2–21.1) 5.0 ± 2.3 (1.8–34.0) 0.5 ± 3.2 (0.05–1.9)
Table 6  Comparison of the 
frequencies of As3MT in 
different populations




 Japanese 370 0.990 0.010 Fujihara et al. (2007)
 Caucasian–American 60 0.900 0.100 Wood et al. (2006)
 Central European 411 0.891 0.109 Lindberg et al. (2007)
 Present study workers 149 0.850 0.150




 Japanese 141 0.587 0.413 Fujihara et al. (2009)
 European – 0.680 0.320 HapMap CEU (www.hapmap.org)
 Argentinean 112 0.760 0.240 Engström et al. (2007)
 Present study workers 149 0.580 0.420




 Japanese 141 0.373 0.628 Agusa et al. (2011)
 European 224 0.696 0.304 HapMap CEU (www.hapmap.org)
 Argentinean 112 0.720 0.280 Fujihara et al. (2009)
 Present study workers 149 0.820 0.180




 European 226 0.381 0.619 HapMap CEU (www.hapmap.org)
 Present study workers 149 0.570 0.430
 Control group 52 0.660 0.340
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European population (Meza et al. 2005; Lindberg et al. 
2007). Moreover, the frequency of C alleles in the Polish 
group was higher than that in the Central European popula-
tion (0.15 vs. 0.11), and two cases of As3MT Thr287Thr 
(rs11191439) individuals were observed. Allele frequencies 
in the case of As3MT 5194 (rs3740400) polymorphism, and 
in the case of As3MT12390 polymorphism, are close to 
that described for European population (Table 6).
An in vitro study indicated that the As3MT Thr (C) vari-
ant demonstrates increased levels of enzyme activity com-
pared to the Met (T) one and a higher capacity of increased 
arsenic methylation (Wood et al. 2006). In addition, studies 
on individuals environmentally exposed to high (Asians, 
South Americans) or low (Central Europeans) As levels 
showed that among rare C allele carriers, the first meth-
ylation capacity of As, expressed as the DMA/MMA ratio 
in urine, was higher than among frequent T allele carri-
ers (Agusa et al. 2011). However, our study did not con-
firm these findings. We found a higher %MMA in asso-
ciation with the Thr allele in Met287Thr (rs 11191439). 
CC+TC wild-type genotype carriers had higher %MMA 
and MMA/iAs (first methylation step) than TT homozy-
gotes. However, it should be emphasized that this is due 
to the influence of the rare allele, because these were CC 
homozygotes that determined the increased excretion of 
MMA These results are consistent with those noted by 
Hernandez et al. (2008) for Chile copper smelting plant 
workers, Agusa et al. (2009) for Vietnam residents and 
Lindberg et al. (2007) for the European population exposed 
to low As levels. Interestingly, a recent in vitro study did 
not confirm the differences in the methylation capacity of 
the As3MT C and As3MT T variants. The only difference 
in the DMA/MMA ratio between frequent and rare As3MT 
alleles was observed for a high As level and the presence 
of glutathione (GSH) in the reaction medium. The author 
suggests that individual variations in the GSH metabolism 
should also be analyzed among the modifiers of As metabo-
lism in humans (Ding et al. 2012).
Several studies on polymorphism of As3MT (rs7085104) 
are interesting, but there is a limited number of them. The 
results concerning the genotype association of As3MT 
4602 (rs7085104) with As metabolism were not consist-
ent among different country groups. Among the subjects, 
As3MT 4602 GG carriers had lower %DMA and higher 
%iAs as well as MMA compared to the other genotypes. 
Although there were no significant differences, the results 
are consistent with the data presented by Agusa et al. 2009. 
Contrary to these results, Valenzuela et al. (2009) noted a 
decrease in %MMA with GG homozygotes in the Mexi-
can population. The effect of As3MT polymorphism (rs 
7085104) was also studied by Schläwicke Engström et al. 
(2009) in an Argentinean female population. He noted an 
influence of this polymorphism on %MMA and %DMA, 
but a much stronger relationship was manifested by rs 
3740400 polymorphism. This is consistent with the results 
obtained in the present work. This polymorphism showed a 
statistically significant effect on the profile of the excreted 
metabolites (Table 4). Recessive homozygotes excreted an 
increased percentage of inorganic arsenic in comparison 
with the other genotypes. Furthermore, only this polymor-
phism in the haplotype analysis shows a functional effect, 
which has also been suggested by Engström et al. (2007). 
In the case of As3MT rs12390 polymorphism, interesting 
relationships are observed. Meza et al. (2005) pointed to a 
higher DMA/MMA ratio in CG+CC than in GG homozy-
gotes, but only in children, and Chung et al. (2009) showed 
a reduced percentage of MMA excretion in the case of the 
GC genotype, compared to the GG genotype in the Taiwan-
ese population. In the studied population, no such relation-
ship was found. Apart from methyltransferase, an important 
group of enzymes involved in the metabolism of arsenic 
are glutathione transferases. In the present work, we inves-
tigated the impact of polymorphism within GSTO2 T>C 
(rs156697) and GSTP1 Ile105Val (rs1695). The results pre-
sented by Marcos et al. (2006), Agusa et al. (2010), Paiva 
et al. (2010), and De Chaudhuri et al. (2008) indicate the 
possible impact of polymorphism within these genes on 
the differences in metabolism and susceptibility to arsenic 
influence in population groups exposed to it environmen-
tally and occupationally. In the case of research conducted 
by Marcos in 105 employees working at a copper smelter, 
the results are consistent with these obtained in the cur-
rent study. Val/Val homozygotes tend to excrete smaller 
amounts of DMA than other genotypes, but the differences 
are not statistically significant (p = 0.0615). More attention 
has been paid to the effect of polymorphism concerning the 
omega class glutathione S-transferases, which is probably 
connected with the antioxidative action of these enzymes. 
GSTO2, non-synonymous Asn142Asp (rs156697) in the 
European population show important influence of this 
polymorphism and the possible varying effects on the 
toxic impact of arsenic. There are large differences in the 
frequencies of particular genotypes in specific populations 
and they mainly are related to the Asp/Asp genotype. Paiva 
et al. (2010) showed an increased percentage of excreted 
DMA in patients with the variant allele, indicating a pos-
sible protective role of this genotype. It is in fact the sec-
ond degree of the methylation process responsible for 
creating the final, least toxic metabolite. In other works, 
such dependence has not been found (De Chaudhuri et al. 
2008; Agusa et al. 2010; Xu et al. 2009). In contrast to 
the above-mentioned authors, in the current work, for the 
occupationally exposed population, statistically significant 
relationships were noted (Table 4) for this polymorphism 
in the dominant model. TT homozygotes (Asn/Asn) excrete 
an increased percentage of MMA, and the MMA/iAs and 
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DMA/MMA ratios are also significantly different com-
pared to the other genotypes.
Our results are in opposition to those obtained in other 
studies covering other populations and focusing on both 
the genetic and environmental factors. The concentration 
of As in the air was discussed as a factor in the methyla-
tion capacity. A methylation threshold hypothesis for iAs 
has been proposed, stating that occupational exposure 
to As at the concentrations above 300 µg/m3 may cause 
inhibition of the methylation process, and when exposure 
to iAs reaches a certain level or threshold, the methyla-
tion capacity begins to decline (Offergelt et al. 1992). The 
results of the epidemiological and experimental human 
studies do not support the methylation threshold hypoth-
esis. The dose level of arsenic has little influence on the 
methylation efficiency (Hopenhayn-Rich et al. 1993; 
Vahter 2000). In the present work, the mean values of 
arsenic species detected in the samples were in agree-
ment with the standard arsenic values (Table 5) (Vahter 
2002), and the geometric mean concentrations of arsenic 
in the air were indeed much lower than the presumed level 
of inhibition of methylation (As-A−27.6 µg/m3). The 
hypothesis concerning the threshold of the methylation 
saturation is not completely explicit. There are studies 
demonstrating the percentage decrease in the concentra-
tions of DMA with a simultaneous increase in the con-
centrations of MMA in the case of growing exposure, 
suggesting inhibition of the methylation process associ-
ated with raised concentrations of inorganic arsenic in 
the tissues. In the other side are studies with opposite 
results confirming higher excretion of DMA following 
the increased exposure (Del Razo et al. 1997). In the con-
text of the above-mentioned hypotheses, the test results 
obtained during the implementation of the current project 
are similar to the assumptions of the methylation satura-
tion process. Nonetheless, the results were in part con-
sistent with other results for the general population and 
splicing variants of the As3MT and GST gene, and their 
function should be further investigated.
Conclusions
The findings of the study point out that the concentration 
of iAs or the sum of iAs + MMA in urine can be a reli-
able biological indicator of occupational exposure to arse-
nic. The present study found that rs3740400 in As3MT 
and rs156697 in GSTO2 were strongly associated with the 
%iAs, %MMA and MMA/iAs andDMA/MMA ratios in 
urine of the occupationally exposed workers and they may 
influence methylation capacity. However, further studies 
investigating genetic polymorphism in occupational condi-
tions are required.
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